Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction to bone biology.

G A Rodan1

  • 1Department of Bone Biology and Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.

Bone
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Bone remodeling involves resorption by osteoclasts and formation by osteoblasts. Imbalances, often from excessive resorption, cause bone diseases, with calcitonin and bisphosphonates directly inhibiting osteoclasts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alendronate: preclinical studies.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.

Prostaglandins, leukotrienes, and essential fatty acids·2006
Same author

Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT.

Bone·2005
Same author

Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins.

Cell death and differentiation·2004
Same author

M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.

Cell death and differentiation·2003
Same author

Preclinical safety profile of alendronate.

International journal of clinical practice. Supplement·2003
Same journal

Baseline β-CTX and BMI predict suitability for deferred zoledronic acid redosing beyond 12 months in postmenopausal Indian women with osteoporosis.

Bone·2026
Same journal

Bone density-based maturation of the midpalatal suture in children aged 8-15 years.

Bone·2026
Same journal

Disrupted phosphate metabolism and SIBLING/ASARM peptide accumulation underlie impaired bone mineralization in klotho-deficient (kl/kl) mice.

Bone·2026
Same journal

Linking genetic variants to bone microstructure: Histological signatures of osteogenesis imperfecta subtypes.

Bone·2026
Same journal

The impact of alcohol consumption on bone mineral density: Insights from cross-sectional and Mendelian randomization studies.

Bone·2026
Same journal

Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study.

Bone·2026
See all related articles

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Bone tissue undergoes continuous remodeling through resorption and formation.
  • An imbalance, particularly excessive resorption, underlies many bone diseases.
  • Osteoclasts mediate resorption, while osteoblasts are responsible for bone formation.

Purpose of the Study:

  • To elucidate the cellular mechanisms of bone remodeling.
  • To identify agents that modulate bone turnover.
  • To understand the roles of osteoclasts and osteoblasts in bone health and disease.

Main Methods:

  • Analysis of osteoclast and osteoblast cellular functions.
  • Investigation of agents affecting bone resorption and formation.
  • Identification of signaling pathways regulating bone turnover.

Related Experiment Videos

Main Results:

  • Osteoclasts resorb bone via a specialized ruffled border with acidic pH and enzymatic activity.
  • Calcitonin and bisphosphonates directly inhibit osteoclast activity.
  • Osteoblasts synthesize bone matrix proteins and their products serve as bone formation markers.
  • Osteoblastic cells regulate bone turnover in response to various systemic and local factors.

Conclusions:

  • Bone remodeling is a tightly regulated process involving distinct cell types and signaling pathways.
  • Dysregulation of osteoclast and osteoblast activity leads to bone pathologies.
  • Targeting osteoclast function offers therapeutic strategies for bone diseases.